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PERIPHERAL VASCULAR DISEASE 
 1-Arterial disease: 
-arterial occlusive dis. 
-fibromuscular dysplasia 
-thromboangiitis obliterans  
(burger dis. ) 
-Raynaud’s 
-Takayasu-giant cell arteritis. 
-Acute arterial occlusion 
-microembolism 
-Levidoreticularis 
-Thoracic outlet syndrome 
-Arteriovenous fistula 
-Acrocyanosis 
-Wound of coldness-frost bite 
-erythromelalgia 
 
 
 
 2-Venous disease: 
-Deep vein thrombosis 
-superficial thrombophlebitis 
-varicose veins 
-Chronic venous insufficiency 
 
 
 
 3-lymphatic vessels: 
-lymphedema 
 
4 
5 
PERIPHRAL 
ARTERIAL DISEASE 
 Peripheral arterial disease (PAD). 
definition:  
-Stenosis or occlusion in the aorta 
or arteries of the limbs. 
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 Atherosclerosis is the leading cause 
of PAD in patients > 40 years old. 
 Other causes include:  
thrombosis,  
embolism,  
vasculitis,  
fibromuscular dysplasia,  
entrapment,  
cystic adventitial disease,  
and trauma. 
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 Highest prevalence of atherosclerotic 
PAD occurs in the 6’’ and 7’’ decades. 
 there is an increased risk of PAD in: 
- cigarette smokers  
- persons with diabetes mellitus,  
- hypercholesterolemia,  
- hypertension,  
- hyperhomocysteinemia. 
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Arterial occlusive disease 
(arteriosclerosis obliterans , ASO) 
 Most common cause of lower extremity 
ischemic syndromes. 
 Fewer than 50% of PAD are symptomatic:  
-many have a slow or impaired gait. 
-Active patient : 
intermittent claudication 
-Inactive patient : 
rest pain, ulceration, dependent rubor with 
edema, or gangrene 
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 Symptoms is distal to level of stenosis: 
 Aortoiliac disease :  
-impotence  
 Internal iliac stenosis:  
-hip and buttock claudication 
 Common femoral  and external iliac dis. :  
-both thigh and calf claudication 
 Superficial femoral dis. :  
-entire calf claudication 
 Popliteal or infrapopliteal disease:  
-foot and calf claudication 
 Important physical findings of PAD: 
-decreased or absent pulses distal to obstruction.  
-Bruits over the narrowed artery. 
-muscle atrophy.  
-With severe disease: hair loss, thickened nails, 
smooth and shiny skin, reduced skin 
temperature, and pallor or cyanosis.  
-with critical limb ischemia: ulcers or gangrene.  
-Legs elevation and repeated flexing of the calf 
muscles produce pallor of the soles of the feet, 
-when the legs are dependent, rubor, secondary 
to reactive hyperemia, may develop. 
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PATHOLOGY 
-Atherosclerotic plaques with calcium 
deposition,  
-thinning of the media,  
-patchy destruction of muscle and elastic 
fibers,  
-fragmentation of the internal elastic 
lamina,  
-and thrombi composed of platelets and 
fibrin. 
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 Primary sites of involvement: 
 femoral and popliteal arteries  
   (80–90% of patients),  
 the more distal vessels, including the 
tibial and peroneal arteries  
   (40–50% of patients).  
 abdominal aorta and iliac arteries  
   (30% of symptomatic patients),  
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prevalence 
 ASO is relatively high prevalence 
 Increases with age 
 Annual incidence in men , 0.3% 
 In women 0.1% 
 Prevalence of int.claud.     1.8% for age<60 
                                          3.7-5% for age >60 
 Risk factor of ASO reflect those for CAD 
 Risk of death increases as the ABI decrease 
 Normal ABI ≥ 1, ABI<0.5 = sever ischemia  
 5-year mortality of an ABI<0.85 is 10%                                                                                                                                                                                                                                                                                                                                               
an ABI<0.40 is 50%     
 Amputation rate is around 1% per year 
 history and physical exam. are often 
sufficient to diagnosis of PAD. 
 
 
 Arterial pressure can be recorded noninvasively 
in the legs by placement of 
sphygmomanometric cuffs at the ankles and 
use of a Doppler device to auscultate or record 
blood flow from the dorsalis pedis and posterior 
tibial arteries.(ABI) 
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Ankle-Brachial Index 
 Comparison of ankle 
pressure to brachial SBP  
 Reproducible, useful for 
long term surveillance 
 Normal 0.85-1.2 
 Claudicants 0.5-0.7 
 Critical ischemia < 0.4 
 May be falsely elevated 
in calcified vessels (DM). 
ABI 
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 Other noninvasive tests include:  
-segmental pressure measurements,  
-pulse volume recordings,  
-Doppler flow velocity waveform analysis,  
-duplex ultrasonography  
  (B-mode imaging and pulse-wave Doppler exam.),  
-transcutaneous oximetry,  
-stress testing (usually treadmill),to assess 
functional limitations. 
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MRA. 
patient with 
intermittent 
claudication, 
showing 
stenoses of the 
distal abdominal 
aorta and right 
common iliac 
artery (A) 
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 stenoses of 
the right and 
left superficial 
femoral 
arteries (B). 
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PROGNOSIS 
 Influenced by the extent of coexisting 
CAD and cerebrovascular disease. 
 
 Patients with PAD have a 15–30% 5-year 
mortality rate ,and a two- to sixfold 
increased risk of death from CAD. 
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Treatment 
 Aggressive Risk factor modification. 
 Smoking cessation/Control of diabetes. 
 Lipid lowering/Hypertension control. 
 Walking program(20-30 min 4-5 days per week). 
 Diligent foot acre. 
 Pentoxyfilline, cilostazol for claud., verapamil. 
 Surgical revascularization. 
 Percutaneous balloon angioplasty, with or 
without stent for proximal renal or iliac 
arteries. 
 
 
DRUG 
 BP control in hypertensive patients. 
  ACEi may reduce the risk of cardiovascular 
events in symptomatic PAD.  
 β-blockers do not worsen claudication and used 
to treat HTN, especially in coexistent CAD. 
  Statins in hypercholesterolemi is reduce the 
risk of MI, stroke and death.  
    (LDL cholesterol to <100 mg/Dl). 
  Platelet inhibitors, particularly aspirin, reduce 
the risk of adverse cardiovascular events in 
peripheral atherosclerosis.  
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  Pentoxifylline, a substituted xanthine 
derivative, decrease blood viscosity and 
increase red cell flexibility, thereby 
increasing blood flow to the 
microcirculation and tissue oxygenation. 
 
 Cilostazol, a phosphodiesterase inhibitor 
with vasodilator and antiplatelet 
properties, increases claudication 
distance by 40–60% and improves 
measures of quality of life. 
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 Anticoagulant warfarin is not 
indicated. 
 Medical treatment of PAD has not 
been as successful as CAD. 
 Adrenergic blocking agents, calcium 
channel antagonists, papaverine, and 
other vasodilators have not been 
effective in patients with PAD. 
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Fibromuscular dysplasia 
 Hyperplastic disorder in medium & small 
artery. 
 Female>male. 
 Common site ,in renal and carotid artery. 
 Dysplasia can be seen in intima, media, 
advantis. 
 Commonest form is medial dysplasia. 
 Treatment: PTA & surgery. 
 histologic classification: 
- Intimal fibroplasia,  
- Medial dysplasia,  
- Adventitial hyperplasia. 
 Medial fibroplasia is the most common 
type ; 
 characterized by alternating areas of 
thinned media and fibromuscular ridges. 
 iliac arteries are the limb arteries most 
likely to be affected by fibromuscular 
dysplasia. 
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Fib.mus.dys.of 
renal artery 
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Fibromusculer 
dyslpasia of 
carotid 
 
Thromboangiitis obliterans (TAO) 
, Bureger’s disease 
 Inflammatory vasculopathy , 
with highly cellular intraluminal 
thrombus, affects small and 
medium-size arteries and veins in 
the distal upper and lower 
extremities. 
 
 Cerebral, visceral, and coronary 
vessels may be affected rarely. 
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 Triad:  
-Claudication,  
-Raynaud,  
-Migratory superficial vein 
thrombophlebitis . 
 Always associated with tobacco 
use. 
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 Predominantly in males in 2” to 5” 
decads. 
 Initial  involvement is digital, pedal, and 
hand vessels, then , calf, thigh, and 
forearm. 
 1/3 of patients reports Raynaud’s 
phenomenon. 
 Angiographic figures are characteristic. 
 Improvement is possible only after 
tobacco ceases. 
 Surgical sympathectomy,arterial 
bypass,debridement ,IV prostacyclin, 
amputtion.    
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 Recurrent superficial thrombophlebitis 
(“phlebitis migrans”) 
 Young adults, heavy smokers, no other 
atherosclerotic risk factors 
 Angiography - diffuse occlusion of distal 
extremity vessels 
 Progression - distal to proximal 
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TAO 
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Raynaud’s  phenomenon 
(periodic ischemia of digits) 
 Definition: episodes of blue or white color 
changes of digits (fingers> toes) , 
followed by reactive hyperemia during 
recovery ,induced by cold or emotion, 
with dead numb feeling in ischemic phase 
,and dysesthetic or painful sensation  
during recovery,  
 diagnosed with history alone. 
 Recovery time is 3 to 10 min, 
   (1 h in advanced cases).  
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 Primary, idiopathic, or Raynaud’s 
disease (50% of Raynaud phenomenon):  
-episodes of bilateral color changes 
induced by cold or emotion  
-without ischemia or other disease , - 
-for 2 years ,  
-most patient require no therapy, 
-F/M = 5 ,age 20-40 ,  
-10% with sclerodactylia.  
 
 Secondary:  
- (50%) , with secondary causes ,that 
treated with underlying cause.  
 Ca blockers and non-beta-adrenergic 
blocking sympatholytics can suppress 
the episodes, with little impact on 
ischemic complication. 
 Ischemic complication are best 
treated with local debridement ,and 
pain-infection controle.   
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Secondary causes of Raynaud’s dis. 
Hematologic disorders 
Environmrntal cold injury 
Atherisclerosis in men>50 
Hypothenar hammer synd. 
Vinyl chloride dis. 
TAO.SLE.RA.sclerodermia 
Neurogenic 
     thoracic outlet synd. 
     carpal tunnel synd. 
Spinal cord tumor     
neuropathy.poliomyelitis 
 
Medication 
   beta blockers, ergotamin 
   methysergide, estrogen 
   Vinblastin, Bleomycin 
   imipramin 
Myxedema , Acromegaly 
 
Pulmonary hypertension 
Vibration syndrome.trauma 
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TREATMENT 
 WARM CLOUTH 
 CIGARETT CESSATION 
 ALPHA BLOKERS:RESERPIN.PRAZOSIN. 
TRAZOSIN.DOXAZOSIN 
 SYMPATHOLITICS:METHYLDOPA… 
 SURGICAL SYMPATHECTOMY. 
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TAKAYASU’S  
AND GIANT CELL ARTERITIS 
  are similar in pathologic process 
  but affect different age groups 
 Takayasu’s arteritis involves below the neck 
 GCA or Temporal arteritis involves above the 
neck 
 Is usually bilateral, results in claudication 
 Progresses briskly , ischemia is rare  
 Elevated ESR. , typical arteriographic fig. 
 Acute stenosis improves with steroid 
 Adjunctive cytotoxic drugs are also useful 
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Acute arterial occlusion 
Clinical pentad of:  
pain , 
pallor, 
paresthesia  
Paralysis                                                                          
pulselessness. 
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Etiology 
 Trauma and dissection  
(penetration, crush or fracture, deceleration injuries) 
 Thrombosis in situ  
(occurs with both occlusive and aneurysmal disease) 
 embolism  
(majority come from the heart, small percentage from  
proximal occlusive or aneurysmal arterial lesion, tend 
to be multiple, recurrent, and to disturb randomly) 
48 
Sites of Embolization 
 Bifurcations 
 Femoral - 40% 
 Aortic - 10-15% 
 Iliac - 15% 
 Popliteal - 10% 
 Upper extremities - 10% 
 Cerebral - 10-15% 
 Mesenteric/visceral - 5% 
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MANAGMENT 
 PROTECT THE LIMB , AND RESTORE BLOOD 
FLOW 
 HEPARIN TO PREVENT CLOT PROPAGATION 
 ANGIOGRAPHY  
 EMBOLECTOMY 
 URGENT REPAIR IN SEVERE ISCHEMIA 
 LYSIS OF ACUTE OCCLUSION , IF INDICATED 
 Acute arterial occlusion, is often 
preventable  
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Microembolism  (Atheroembolism)  
 Usually originates from ulcerative plaque(atheroemboli) 
or aneurysm and rarely from the heart 
 Blue toe syndrome , and levido reticularis in skin 
 Solitary lesion showering atheroemboli: surgery 
 Suprarenal sources: azotemia 
 Aortic Thromboulcerative dis.: shower emboli randomly 
to brain, viscera, kidney, skin and muscle 
 anemia, leukocytosis, azotemia, elevated ESR, 
abnormal U/A , usually are noted 
 Microembolism May be spontaneous, or percipitated by 
surgery, instrumentation, or anticoagulation therapy 
 Platelet inhibitors for prevention, and surgery for treat.    
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LIVEDO RETICULARIS 
 Definition: persistent, symmetric, bluish lacy 
pattern on the extremities and sometimes the 
trunk, variable in intensity and extent, most 
apparent by cold or emotion, and fades by 
warmth and exercise, first seen in childhood or 
puberty and more common in women and fair-
skinned individuals 
  
 Spasm of cutaneous arterioles with secondary 
dilatation of capillaries and venules , causes 
slow flow ,increased oxygen uptake reduced 
oxyhemoglobin , and color change  
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Livedo reticularis 
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 Primary: seen with 
acrocyanosis and 
raynaud’s 
phenomenon, 
treatment is rarely 
needed 
 Secondary: is patchy, 
focal, asymmetric, 
late in onset, may by 
complicated by 
infarction and 
ulceration 
Treatment is directed to 
underlying cause, 
Avoidance of coldness 
 
etiologies 
Environmental 
(cold) 
Reflex 
sympathetic 
dystrophy 
Atheroembolism 
(cholesterol) 
Myeoproliferative 
dis 
Connective tissue 
dis 
Vasculitis 
Cutaneous 
vasculitis 
thrombocytosis 
Amantadine HCL 
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Thoracic outlet syndrome 
 An osseous lesion( commonly a cervical rib) ,or muscular 
abnormality causes an aneurysm or stenosis of 
subclavian artery, predisposes to thrombosis 
and Raynaud’s phenomenon (a scissors of cervical or first 
rib with clavicle) ,or compress the brachial plexus  
 Venous-neurogenic complaint may present 
 Young active patient , complaint of arm fatigue 
, swelling, or paresthesia  
 Diagnosis: ultrasound, arteriography, and 
clinical correlation 
 Correction: Resection of cervical rib or first rib 
or resection of the scalenus anticus muscle.  
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Thoracic Outlet Syndrome 
 Upper extremity symptoms due to 
compression of the neurovascular bundle 
in the thoracic outlet area 
 3 Types 
 Neurogenic - most common (95%) 
 Venous 2-3% 
 Arterial 1% 
 Exacerbated by elevation, abduction, 
hyperextension of arm 
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Thorasic 
outlet 
syndrome 
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Arteriovenous fistula 
 Abnormal communication between artery 
and venous 
 Congenital , aqcuired (by physician, for vascular 
access in hemodialysis , or trauma such as stab wound 
and …) 
 Pulsetile tumor, with bruie, and trill , 
occasionally high CO –CHF  
 Treatment:  
supportive such as elastic stocking , 
interventive such as Embolisation, 
stenting, surgery,…. 
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AV fistula 
61 
Arteriovenous fistula in sinus 
cavernous 
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Acrocyanosis  
(arterial constriction & capillary and venouls dilatation) 
 Definition:  
benign, persistent  cyanotic discoloration and coolness of 
hands or fingers or sometimes feet,  
-seen more commonly in women ,  
-intensify with cold and emotion,  
-ameliorate with warmth and exercise , 
-sometimes mild local edema,  
-painless,  
-dose not ulcerated,  
-but a cosmetic problem,  
-Associated hyperhidrosis may require treatment. 
 Ca blockers or alpha antagonists often reduced 
symptom   
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Acrocyanosis 
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Pernio  
(wound of coldness- Chilblains) 
 
 A vasculitis disorder in conjunction with 
coldness 
 In lower portion of calf and foot 
 Treatment : warmth, and wound 
management 
  sympatholytic drugs 
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PERNIO 
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PERNIO 
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Frostbite 
 Tissue damage in very cold environment 
 Cyanosis, erythema, urticaria, edema, and 
superficial bolouse with warmth  
 Hand and foot edema and gangrene 
 Treatment: 40-44 centigrade warm bath 
and dressing with analgesic and antibiotic 
if indicated ,  
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frostbite 
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Erythromelalgia 
 Pain and erythem of upper and lower 
extremity in conjunction with heat, 
relief with coldness ,water and 
upstanding 
 Foots>Hands 
 Male> Female 
 Primary , 
 secondary to myeloproliferative disease 
  aspirin in secondary to 
myeloproliferative dis. May be usefull . 
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Erythromelalgia 
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Venous disease 
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Deep Vein Thrombosis 
Risk factors: 
 Immobility 
 Recent surgery 
 Progesterone 
therapy 
 Residency in care 
facility 
 Prior DVT 
   
 Hospitalization 
 Malignancy 
 Trauma 
 Prior 
sup.thrombo.phl. 
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Acute pelvic  
deep vein 
thrombosis 
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 Manifestations: prominent 
superficial venous pattern, 
edema, muscle turgidity, and 
discomfort . 
  these findings may be absent.  
 Less than 50% of DVT , have the 
diagnosis confirmed when tested 
objectively. 
78 
 Treatment :heparin(PTT 2 time of normal level) and 
warfarin(INR 2-3) for 12-16 weeks (6-12 month for 
spontaneous DVT) to preventing clot propagation 
and pulmonary embolism . 
 Caval occlusive procedures (filter), when 
anticoagulants are contraindicated 
 Early Thrombolytic therapy accelerates 
recovery and reduce incidence or severity of 
postphlebitic syndrome 
 Long-term compression stocking to the knee 
reduces the incidence of postphlebitic synd. , 
venous stasis changes, and venou ulceration. 
 Direct trombin inhibitor,lepirudin, or 
Argatroban, if heparin is contraindicated due to 
thrombocytopenia.  
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Superficial thrombophlebitis 
 Definition: warm, tender, erythematous, indurated 
,linear lesion in the anatomic course of a superficial 
vein  
 D.D: lymphangitic streaks, erythema nodosum . 
Differentiated with ultrasound 
 Often occur at site of indwelling catheter or needles , 
may be infected 
 Suppurative thrombophlebitis often requires surgical 
removal  
 Can be idiopathic or associated with malignancy , TAO, 
or vasculitis  
 Usually is self limited , but rest, topical warmth, and 
NSAIDS ,(anticoagulant if indicated)  accelerated recovery.  
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varicose veins 
 Incompetence of one or more valves or vein 
wall produce varicosities of superficial veins 
Primary :often a familial trait , symptoms 
exacerbated by prolong standing, obesity, 
and pregnancy 
Secondary : reflect underlying perforator and 
deep venous obstruction.  
common cause include: extrinsic venous 
compression, prior DVT, congenital lesion, AV 
fistula, and RV failure  
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 Symptom: ache or burn with standing or 
prolong sitting enlargement over time 
,and superficial thrombophlebitis , rarely 
may bleed that is brisk 
 Graduated compression stocking of 20-30 
mmhg ameliorate symptoms and 
progression  
 Ablation of vein if interferes with lifestyle 
 Sclerotherapy is effective in certain 
varico. 
 Surgical removal for longer segments 
,especially if perforator or 
saphenofemoral is incompetence 
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Chronic venous insufficiency 
 Definition:  
 Chronie deep vanous incompetence or 
obstruction 
 Chronic venous insufficiency may result from 
DVT and/or valvular incompetence 
 Leg edema, venous dilatation, intradermal  
deposition of proteins and hemosiderin, 
cutaneous fibrosis, lichenification, cellulitis , 
and ulceration 
 Symptom:  
 heavy congested limb, venous claudication, 
pruritus, and  painless skin ulceration 
 Predisposing f. :prior DVT, chronic RV failure, 
an AV fistula 
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 Diagnosis:  
Doppler, ultrasound, and venography                                       
 Treatment:  
-reduction of edema, control of venous 
hypertension with rigid or elastic support 
at 30-40 mmhg of compression  
-Repair or replacement of proximal valves, 
bypass of iliocaval obstruction 
-Patients should be advised to avoid 
prolonged standing or sitting  
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Laboratory assessment: 
 CT, MRI & venography for evaluation of 
venous system 
 Venography is gold standard for DVT 
determination 
 duplex ultrasound is most commonly used 
method, it has advantage for differentiates 
acute from old thrombus  
 Continuous wave doppler detects the 
movement of blood  
 Plethysmography for venous incompetence  
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Lymphatic 
disorders 
90 
LYMPHEDEMA 
Etiology: 
Primary: may be present at birth, isolated, or 
part of a congenital familial syndrome 
Secondary: more common, with trauma, 
recurrent infection, obstruction by mass, 
infiltrative processes, or direct damage by 
irradiation , after radical mastectomy 
Recurrent cellulitis is common in 
lymphedema, with streptococcus in toe 
trychophytosis . 
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Diagnosis:  
 History & physical examination 
 Edema involve the toes 
 Skin is thickened (peau d’ orange) 
Testing: 
 Lymphangiography,injection in lymphatic 
vessle, that is more dificult 
 Lymphoscintigraphy , with Tc99 labeled 
antimony trisulfid injected in 
subcutaneous tissue at distal site, that is 
easier and low risk.  
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Treatment: 
Compression, reduce size with 
elevation, mechanical pumping, or 
manual massage 
Then, compression garment of 40-50 
mmhg worn daily     
Early treatment of cellulitis and fungal 
infection 
Finally, lymphatic venous anastomosis 
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